The Forum entitled “European Cooperation on HTA: What’s next?” is jointly organized by the European Commission and EUnetHTA and EC on the 21st of October 2016 in Brussels (The Square conference center).
On the 7th June 2016, a technical meeting was held in Paris, hosted by Haute Autorité de Santé (HAS, EUnetHTA Work Package 5 lead). The participants of this meeting not only included all EUnetHTA Joint Action 3 WP leads, but also representatives from industry (pharmaceutical), European Federation of Pharmaceutical Industries and Associations (EFPIA), European Medicines Agency (EMA), HTA agencies and the European Commission.
The Dutch National Health Care Institute and the European Commission signed the Grant Agreement on the 25th of August 2016. Within 30 days all organisations need to sign in order to join the creation of sustainable HTA network. Then Joint Action 3 will start officially.
EUnetHTA JA3 is organized into three horizontal work packages (WP1-3), and four core work packages (WP4-7). The core work packages will deliver products needed for a sustainable HTA network like quality joint assessments, evidence generation, quality management and focus on implementation of this model on national, regional and local levels.
The horizontal work packages will coordinate the Joint Assessment, disseminate its results and evaluate the main objective of this Joint Assessment.
This work package focuses on the production of joint health technology assessments. The joint assessments should be fit for purpose, of high quality, of timely availability, and cover the whole range of health technologies.
Aims Joint Action 3 aims to define and implement a sustainable model for the scientific and technical cooperation on Health Technology Assessment (HTA) in Europe. The voluntary cooperation within and between national and regional HTA Bodies is essential in this joint action.